Effects of carbamazepine, eslicarbazepine, valproic acid and levetiracetam on bone microarchitecture in rats
- 19 March 2020
- journal article
- research article
- Published by Springer Nature in Pharmacological Reports
- Vol. 72 (5) , 1323-1333
Abstract
Background Metabolic bone disease and fractures are a great problem for patients with epilepsy. The use of antiepileptic drugs (AEDs) is known to play an essential role in the progression of bone loss by various pathophysiological mechanisms. The aim of this study was to evaluate the effects of AEDs on bone microstructure as an additional cause of an increased fracture risk in patients with epilepsy. Methods Five groups of each of 12 female rats were orally dosed daily for 8 weeks with either carbamazepine (CBZ) (60 mg/kg), eslicarbazepine (ESL) (80 mg/kg), valproic acid (VPA) (300 mg/kg), levetiracetam (LEV) (50 mg/kg) or saline (control (CTL)). Following killing, dissected femurs were analyzed using X-ray micro-computed tomography (µCT), dual-energy X-ray absorptiometry (DXA) and biomechanical testing. In addition, serum bone turnover markers (BTM) were monitored throughout the experiment. Results Compared to CTL treatment, VPA decreased bone volume fraction by 19%, decreased apparent density by 14% and increased structural model index by 41%. No changes were observed in bone biomechanics nor mineral density evaluated by DXA or in levels of BTM. Conclusions Our findings suggest that VPA affects the microarchitectural properties of the bone. The AEDs CBZ, ESL and LEV appear to have less adverse effects on bone biology and may be a better choice when treating patients with respect to bone health.Keywords
Funding Information
- Eisai Co.
- Jascha Fonden
- Fonden til Lægevidenskabens Fremme
This publication has 46 references indexed in Scilit:
- Exposure to CYP3A4‐inducing and CYP3A4‐non‐inducing antiepileptic agents and the risk of fracturesPharmacoepidemiology and Drug Safety, 2011
- Microindentation for in vivo measurement of bone tissue mechanical properties in humansJournal of Bone and Mineral Research, 2010
- Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: Findings from the women's health initiative (WHI)Journal of Bone and Mineral Research, 2010
- Antiepileptic drug use and rates of hip bone loss in older menNeurology, 2008
- Predictors of bone density in ambulatory patients on antiepileptic drugsBone, 2008
- Bone health in young women with epilepsy after one year of antiepileptic drug monotherapyNeurology, 2008
- Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitorsBMC Genomics, 2007
- Levetiracetam, Phenytoin, and Valproate Act Differently on Rat Bone Mass, Structure, and MetabolismEpilepsia, 2007
- Histone Deacetylase Inhibitors Promote Osteoblast MaturationJournal of Bone and Mineral Research, 2005
- Bone Complications of AnticonvulsantsDrugs, 1976